-
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion
03 Nov 2025 13:30 GMT
… EMA) of its pivotal Phase 3 Serenta trial in patients … clinical trial in Europe and is similar to the Investigational New Drug … milestones for our eRapa Phase 3 program in FAP. We … double-blind, placebo-controlled Phase 3 registrational study designed to …
-
Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025
03 Nov 2025 13:00 GMT
… Supraventricular Tachycardia (PSVT) Across Multiple Clinical Trials,” will be presented on Monday … (open-label extensions). A New Drug Application (NDA) for CARDAMYST is … with a robust clinical trial program that includes a completed Phase 3 clinical-stage …
-
Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights
03 Nov 2025 13:30 GMT
… company that is transforming clinical trials with AI powered precision … NetraAI platform to a Phase 3 clinical trial of a novel psychiatric … trial insights that support drug development success for its … making in late-stage drug development and provide clear, …
-
Recce progresses phase 3 clinical trial and expands global...
03 Nov 2025 03:35 GMT
… underway in Recce’s registrational Phase 3 clinical trial for diabetic foot infections (DFI … increased approval timelines for new drugs while making it cheaper and … foreign sponsors to conduct clinical trials locally. Recce’s Phase 3 program is among …
-
Otsuka Pharma enters licensing agreement with 4D Molecular Therapeutics for ophthalmic gene therapy drug candidate, 4D─150
03 Nov 2025 05:39 GMT
… to 16 weeks. These drugs inhibit vascular endothelial growth … a single intravitreal injection. Clinical trials to date have demonstrated … continue to lead all phase 3 clinical activities globally, including … 4FRONT-2, the global phase 3 study in nAMD, are …
-
AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
02 Nov 2025 01:59 GMT
… this treatment further in the Phase 3 clinical trial OCEAN(a)-Outcomes, which … the future. Even when clinical trials are successful, regulatory authorities … U.S. Food and Drug Administration, and no conclusions … Raal F. AMG-145. Drugs of the Future. 2013;38 …
-
AstraZeneca’s gMG drug fails to fend off rivals despite Phase III win
02 Nov 2025 01:26 GMT
… In the Phase III PREVAIL study (NCT05556096), the drug offered a … leading industry insights.
Clinical Trials Arena Excellence Awards … you deserve! The Clinical Trials Arena Excellence Awards … top leaders driving clinical trials industry advancements. Don …
-
Federally Funded Cancer Clinical Trials Play a Vital Role
01 Nov 2025 19:29 GMT
… .
“Federally funded cancer clinical trials play an important role … contrast, were more often Phase III trials, which test new … often involved complex multimodality drug or biological agent combinations … of federally funded cancer clinical trials. “A 2024 ASCO …
-
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025
30 Oct 2025 20:30 GMT
… degrader (SERD), currently in two Phase 3 clinical trials. In addition, Olema is developing … granted U.S. Food and Drug Administration (FDA) Fast Track designation … ribociclib in the ongoing pivotal Phase 3 clinical trial, OPERA-02. Palazestrant is also …
-
AbbVie posts another win for Rinvoq in Phase III vitiligo trials
30 Oct 2025 19:04 GMT
… to commercialise copycat drugs by the drug’s patent … being explored in the Phase III Tranquillo (NCT05583526) study. … you deserve! The Clinical Trials Arena Excellence Awards celebrate … among top leaders driving clinical trials industry advancements. Don’ …